OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001489902

CHINA GEWANG BIOTECHNOLOGY, INC.

CHINA GEWANG BIOTECHNOLOGY, INC. (CIK 0001489902, EIN 42-1769584) reported revenue of $45.52 million ($45,519,999) for FY2016 (2015-12-01 to 2016-11-30) and net income of $13.57 million ($13,574,670) for FY2016 (2015-12-01 to 2016-11-30), as filed in its 10-K filed 2017-02-10 (accession 0001213900-17-001201).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends November 30).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001489902
EIN42-1769584
SIC industry code2000 Food and Kindred Products
State or country of incorporationNV
Fiscal year endNovember 30
Filer categoryAccelerated filer
Entity typeoperating
Olympus entity IDorg_7an92mv75jerqqetnvz3a0n1jr
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$45,519,999FY20162015-12-01 to 2016-11-3010-K2017-02-100001213900-17-001201Revenues
Net income$13,574,670FY20162015-12-01 to 2016-11-3010-K2017-02-100001213900-17-001201NetIncomeLoss
Total assets$36,203,497FY2016as of 2016-11-3010-K2017-02-100001213900-17-001201Assets
Total liabilities$5,204,643FY2015as of 2015-11-3010-K2016-02-290001511164-16-000664Liabilities
Stockholders' equity$31,133,185FY2016as of 2016-11-3010-K2017-02-100001213900-17-001201StockholdersEquity
Operating cash flow-$2,835,968FY20162015-12-01 to 2016-11-3010-K2017-02-100001213900-17-001201NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share$0.02 per shareFY20152014-12-01 to 2015-11-3010-K2016-02-290001511164-16-000664EarningsPerShareBasicAndDiluted
Shares outstanding75,000,000 sharesFY2016as of 2017-02-1010-K2017-02-100001213900-17-001201EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2007-2016, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20162015-12-01 to 2016-11-30$45,519,99910-K2017-02-100001213900-17-001201
RevenueFY20152014-12-01 to 2015-11-30$4,184,25510-K2017-02-100001213900-17-001201
Net incomeFY20162015-12-01 to 2016-11-30$13,574,67010-K2017-02-100001213900-17-001201
Net incomeFY20152014-12-01 to 2015-11-30$1,188,71310-K2017-02-100001213900-17-001201
Net incomeFY20142014-01-01 to 2014-12-31-$36,56610-K2015-04-210001511164-15-000222
Net incomeFY20132013-01-01 to 2013-12-31-$26,58810-K2015-04-210001511164-15-000222
Net incomeFY20122012-01-01 to 2012-12-31-$26,05510-K2014-03-310001511164-14-000157
Net incomeFY20112011-01-01 to 2011-12-31-$27,09010-K/A2013-06-210001214659-13-003555

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2017-07-172017-05-310001213900-17-007609f10q0517_chinagewang.htm
10-Q2017-04-122017-02-280001213900-17-003638f10q0217_chinagewang.htm
10-K2017-02-102016-11-300001213900-17-001201f10k2016_chinagewangbio.htm
10-Q2016-10-142016-08-310001511164-16-001076f10q8312016.htm
10-Q2016-07-152016-05-310001511164-16-000936f10q5312016.htm
10-Q2016-04-152016-02-290001511164-16-000778f10q.htm
10-K2016-02-292015-11-300001511164-16-000664form10k.htm
10-Q2015-10-202015-08-310001511164-15-000506f10qaugust312015.htm
10-Q2015-07-222015-05-310001511164-15-000362form10q515v2.htm
10-Q2015-04-212015-03-310001511164-15-000224form10q315.htm
10-K2015-04-212014-12-310001511164-15-000222form10k2014.htm
10-Q2014-10-222014-09-300001511164-14-000601f09301410q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001489902published by the sourcedata.sec.gov/submissions/CIK0001489902.json2026-10-21
Employer Identification Number (EIN) · US-EIN42-1769584published by the sourcedata.sec.gov/submissions/CIK0001489902.json2026-10-21

Former names

NameFromTo
RICH STAR DEVELOPMENT, CORP2010-04-212014-12-03

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001489902.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001489902.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001489902" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001489902/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001489902/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1489902"}

On SEC EDGAR

About this data